Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

The ability to respond to changing surroundings was once considered exclusive to complex living organisms. Then came ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Recursive OS Powered by Symbolic Intelligence Ushers In a New Category of AI Built for Founders, Builders, and Operators Shaping What’s Next ...

The latest Call of Duty fumbles its much-anticipated campaign, while zombies and multiplayer modes retain the status quo.

Mandated DNS blocking is the wrong tool for public policy enforcement. The DNS exists to make the Internet usable, not to serve as a mechanism of control.

Cathie Wood’s ARK ETF published their daily trades for Tuesday, November 18, 2025, showcasing significant activity in several notable stocks. The largest transaction of the day was the purchase of ...

Conflicts, trade wars, inequality and democratic decay fill today’s headlines. Each crisis appears to be feeding the next, and it can feel as though the world is coming apart. Western leaders and ...